DPO-1

1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

DPO-1 is a potent Kv1.5 and Kv1.3 (EC50 = 3.1 μM) channels inhibitor with potential immunomodulatory and anti-inflammatory effects. DPO-1 reduces Kv1.3 current density, blunts Ca2+ influx in Ca2+-depleted Jurkat cells, and inhibits IL-2 secretion in activated Jurkat cells. DPO-1 inhibits Uric acid sodium (HY-B2130A) (MSU)-induced NLRP3 inflammasome activation by blocking Kv1.5-mediated K+ efflux. DPO-1 can be used for the study of immunologic disorders and atrial fibrillation.

For research use only. We do not sell to patients.

  • Purity: 98.39%
  • CAS No.: 43077-30-1
  • Formula: C22H29OP
  • Molecular Weight:340.44
  • Storage:
    Powder   -20°C, 3 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need

Publications Citing Use of MedChemExpress (MCE) DPO-1

More

All NOD-like Receptor (NLR) Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00